Related Experiment Video
Updated: Nov 7, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Infective endocarditis and outcomes of mitral valve replacement
Vesa Anttila1, Markus Malmberg1, Jarmo Gunn1
1Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
Background:
We investigated the long-term outcomes of mitral valve replacement (MVR) in native mitral valve infective endocarditis (IE).
Methods:
Multicentre, population-based cohort register study consisted of 1233 consecutive adult patients treated with first-time MVR in Finland. Mitral valve IE was diagnosed in 170 of these patients. Propensity score matching resulted in 134 pairs with balanced baseline characteristics. The median follow-up was 6.1 years.
Results:
Pre-operative native mitral valve IE was associated with an increased hazard of 10-year mortality (38.8% vs 30.5%; HR 2.13; CI 1.17-3.85; P = .013) after MVR. Occurrence of major bleeding was higher in IE patients (26.0%) vs non-IE patients (23.4%) during the 10-year follow-up (HR 2.80; CI 1.01-7.77; P = .048). Hospital admission duration after MVR was longer in IE patients (median 28 vs 11 days; P < .0001). Cumulative ischaemic stroke rate was similar between patient groups (12.1% in IE vs 15.1% in non-IE; P = .493). Re-sternotomy was performed in 13.4% of IE patients and 9.0% of non-IE patients (P = .261).
Conclusions:
Patients with native mitral valve IE have a higher risk of death and major bleeding after MVR than matched patients without IE. Results highlight the importance of complication prevention in these patients.
Insights
Patients with native mitral valve infective endocarditis (IE) face higher mortality and bleeding risks after mitral valve replacement (MVR). Early complication prevention is crucial for improved outcomes in IE patients undergoing MVR.
Area of Science:
- Cardiovascular Surgery
- Infectious Diseases
- Clinical Outcomes Research
Background:
- Native mitral valve infective endocarditis (IE) poses significant challenges in cardiac surgery.
- Understanding the long-term sequelae of mitral valve replacement (MVR) in IE patients is critical.
Purpose of the Study:
- To evaluate the long-term outcomes of MVR in patients with native mitral valve IE.
- To compare mortality, bleeding events, and other complications between IE and non-IE patients post-MVR.
Main Methods:
- A multicentre, population-based cohort study included 1233 adult patients undergoing first-time MVR.
- 170 patients had mitral valve IE; propensity score matching created 134 matched pairs.
- Median follow-up was 6.1 years.
Main Results:
- Pre-operative IE was linked to increased 10-year mortality (38.8% vs 30.5%) and higher major bleeding rates (26.0% vs 23.4%) after MVR.
- IE patients experienced longer hospital admissions (28 vs 11 days).
- Ischemic stroke and re-sternotomy rates were similar between groups.
Conclusions:
- Native mitral valve IE significantly increases the risk of death and major bleeding post-MVR.
- These findings underscore the necessity of proactive complication prevention strategies for IE patients undergoing MVR.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction

